The Effects of Transcranial Direct Current Stimulation on Central Pain in Patients With Spinal Cord Injury
This study has been completed.
Sponsor:
Seoul National University Bundang Hospital
Information provided by (Responsible Party):
Hyung-Ik Shin, Seoul National University Bundang Hospital
ClinicalTrials.gov Identifier:
NCT01781065
First received: January 29, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the analgesic effect of transcranial direct current stimulation (tDCS) applied on motor cortex in patients with spinal cord injury who have chronic neuropathic pain.
| Condition | Intervention | Phase |
|---|---|---|
|
Neuropathic Pain Spinal Cord Injury |
Device: transcranial direct current stimulation |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Analgesic Effect of Transcranial Direct Current Stimulation Over the Primary Motor Cortex on Central Neuropathic Pain Patients With Spinal Cord Injury |
Resource links provided by NLM:
Further study details as provided by Seoul National University Bundang Hospital:
Primary Outcome Measures:
- Numeric rating scale for average pain over the preceding 24h [ Time Frame: before the first tDCS session, and 1, 2, 4, 6 and 8 wk after the start of the stimulation ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Patient global impression of change for pain [ Time Frame: before the first tDCS session, and 1, 2, 4, 6, and 8 wk after the start of the stimulation ] [ Designated as safety issue: No ]
Other Outcome Measures:
- Pain interference in general daily life, mood and sleep [ Time Frame: before the first tDCS session, and 1, 2, 4, 6, 8 wk after start of the stimulation ] [ Designated as safety issue: No ]
| Enrollment: | 11 |
| Study Start Date: | March 2008 |
| Study Completion Date: | February 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: transcranial direct current stimulation
Anodal stimulation on motor cortex using transcranial direct current stimulation
|
Device: transcranial direct current stimulation
Other Name: Iomed Phoresor II Auto
|
Detailed Description:
- anodal stimulation of the primary motor cortex (M1)
- anode electrode: C3 (EEG 10/20 system)
- cathode electrode: contralateral supraorbital area
- constant current of 2mA intensity for 20 min
- twice a day with a more than 4 hours interval during of 2 weeks (from Monday to Friday, total 20 treatment session)
Eligibility| Ages Eligible for Study: | 30 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- elapsed time since spinal cord injury more than 6 months
- stable chronic pain for at least 3 preceding months
- pain that was not attributable to cause other that neuropathic pain
- pain that was resistant to various types of medications or physical or complementary medicine treatment
Exclusion Criteria:
- any kind of metal implant in the head
- heart disease including having a cardiac maker
- family or personal history of epilepsy, or neuropsychiatric illness
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01781065
Locations
| Korea, Republic of | |
| Seoul National University Bundang Hospital | |
| Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-802 | |
Sponsors and Collaborators
Seoul National University Bundang Hospital
Investigators
| Principal Investigator: | Hyung Ik Shin | Seoul National University Bundang Hospital |
More Information
Publications:
| Responsible Party: | Hyung-Ik Shin, Associate Professor, Seoul National University Bundang Hospital |
| ClinicalTrials.gov Identifier: | NCT01781065 History of Changes |
| Other Study ID Numbers: | 11-2008-010 SNUBH |
| Study First Received: | January 29, 2013 |
| Last Updated: | January 29, 2013 |
| Health Authority: | Korea: Food and Drug Administration |
Additional relevant MeSH terms:
|
Neuralgia Spinal Cord Injuries Pain Neurologic Manifestations Nervous System Diseases Peripheral Nervous System Diseases |
Neuromuscular Diseases Signs and Symptoms Spinal Cord Diseases Central Nervous System Diseases Trauma, Nervous System Wounds and Injuries |
ClinicalTrials.gov processed this record on May 22, 2013